West Nile virus infection in plasma of blood and plasma donors, United States

Emerging Infectious Diseases

Volumn 15, Issue 10, 2009, Pages 1668-1670

  Planitzer, Christina B ^a   Modrof, Jens ^a   Yu, Mei Ying W ^b   Kreil, Thomas R ^a  

^a BAXTER BIOSCIENCE   (Austria)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PLASMA; PREVALENCE; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 70349973308     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1510.081668     Document Type: Article

References (14)

1. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395-402.
2. Planitzer CB, Modrof J, Kreil TR. West Nile virus neutralization by US plasma-derived immunoglobulin products. J Infect Dis. 2007;196:435-440 DOI: 10.1086/519392 (Pubitemid 47093894)
3. Ehrlich HJ, Muller M, Oh HM, Tambyah PA, Joukhadar C, Montomoli E, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med. 2008;358:2573-2584 DOI: 10.1056/NEJMoa073121 (Pubitemid 351831358)
4. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005;353:460-467 DOI: 10.1056/NEJMoa044029 (Pubitemid 41127290)
5. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451-459 DOI: 10.1056/NEJMoa044333
6. Mandalakas AM, Kippes C, Sedransk J, Kile JR, Garg A, McLeod J, et al. West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis. 2005;11:1774-1777
7. Meyer TE, Bull LM, Cain HK, Pascua RF, Travassos da Rosa A, Gutierrez CR, et al. West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis. 2007;13:1500-1503 PMID: 18257995 (Pubitemid 350006984)
8. Schweitzer BK, Kramer WL, Sambol AR, Meza JL, Hinrichs SH, Iwen PC. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314-318 DOI: 10.1128/CVI.13.3.314-318.2006
9. Schellenberg TL, Anderson ME, Drebot MA, Vooght MT, Findlater AR, Curry PS, et al. Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health. 2006;97:369-373
10. Murphy TD, Grandpre J, Novick SL, Seys SA, Harris RW, Musgrave K. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis. 2005;5:246-251 DOI: 10.1089/vbz.2005.5.246
11. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-264 DOI: 10.1016/S0140-6736(01)05480-0
12. Michaels SR, Balsama GA, Kukreja M, Anderson C, Straif-Bourgeois S, Talati G, et al. Surveillance for West Nile virus cases in Louisiana 2001-2004. J La State Med Soc. 2005;157:269-272
13. Audet S, Virata-Theimer ML, Beeler JA, Scott DE, Frazier DJ, Mikolajczyk MG, et al. Measles-virus-neutralizing antibodies in intravenous immunoglobulins. J Infect Dis. 2006;194:781-789 DOI: 10.1086/506363
14. Samuel MA, Diamond MS. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80:9349-9360 DOI: 10.1128/JVI.01122-06